Search Within

Andrew D Seidman

  1. "2011"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (6)
Groups
  1. Breast Medicine Service (13)
  2. Department of Medicine (13)
  3. Solid Tumor Oncology Division (13)
  4. Survivorship Research (5)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  6. Biostatistics Service (3)

More Groups

People
  1. Clifford Hudis (5)
  2. Larry Norton (4)
  3. Maura Dickler (3)
  4. Shanu Modi (3)
  5. Sujata Patil (3)
  6. Alison Conlin (2)

More People

Years
  1. 2011 (13)
Publications
  1. Journal of Clinical Oncology (5)
  2. Annals of Oncology (3)
  3. Cancer Research (3)
  4. Clinical Cancer Research (1)
  5. Current Oncology Reports (1)
Publishers
  1. American Society of Clinical Oncology (5)
  2. American Association for Cancer Research (4)
  3. Oxford University Press (3)
  4. Springer (1)

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tesetaxel, an advanced-generation oral taxane, as first-line treatment in women with metastatic breast cancer
    Meeting Abstract

    Schwartzberg, L. S.; Beeram, M.; Patnaik, A.; Tolcher, A. W.; Itri, L.; Olson, A. L.; Seidman, A. D.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Evaluation of response rate and disease control rate as potential predictors of overall survival in anthracycline-pretreated women receiving first-line chemotherapy for metastatic breast cancer (MBC)
    Meeting Abstract

    Liu, J.; Albain, K. S.; Chan, S.; Seidman, A. D.; Tai, D.; Wang, Y.; Zhao, L.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Hepatic arterial infusion (HAI) in the treatment of breast cancer with liver metastases (BCLM) in patients (pts) who progressed after hormonal and systemic chemotherapy (CTx)
    Meeting Abstract

    Herran, L. A.; Jhaveri, K. L.; Seidman, A. D.; Patel, D.; Gewirtz, A. N.; Kemeny, N. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I study in patients with metastatic HER2-amplified breast cancer
    Meeting Abstract

    Gajria, D.; King, T. A.; Pannu, H.; Sakr, R.; Seidman, A. D.; Syldor, A.; Patil, S.; Maybody, M.; Norton, L.; Rosen, N.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Tesetaxel, an oral taxane, as first-line therapy for women with metastatic breast cancer
    Meeting Abstract

    Schwartzberg, L.; Rubin, P.; Patnaik, A.; Itri, L.; Olson, A. L.; Seidman, A. D.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Randomized phase II trial of weekly vs. q 2-weekly vs. q 3-weekly nanoparticle albumin-bound paclitaxel with bevacizumab as first-line therapy for metastatic breast cancer
    Meeting Abstract

    Seidman, A. D.; Conlin, A. K.; Bach, A.; Forero-Torres, A.; Wright, G.; Hackney, M. H.; Clawson, A.; Schofield, D.; Iglesias, J.; Hudis, C. A.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I/II study in patients with metastatic HER2-amplified or triple-negative breast cancer
    Meeting Abstract

    Gajria, D.; King, T.; Pannu, H.; Sakr, R.; Seidman, A. D.; Modi, S.; Dickler, M.; Drullinsky, P.; Syldor, A.; Sujata, P.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer
    Journal Article

    Fornier, M. N.; Morris, P. G.; Abbruzzi, A.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C.; Dickler, M.; Modi, S.; Seidman, A. D.; more...
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • Breast carcinoma with brain metastases: Clinical analysis and immunoprofile on tissue microarrays
    Journal Article

    Brogi, E.; Murphy, C. G.; Johnson, M. L.; Conlin, A. K.; Hsu, M.; Patil, S.; Akram, M.; Nehhozina, T.; Jhaveri, K. L.; Hudis, C. A.; more...
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer
    Journal Article

    Seidman, A. D.; Brufsky, A.; Ansari, R. H.; Hart, L. L.; Stein, R. S.; Schwartzberg, L. S.; Stewart, J. F.; Russell, C. A.; Chen, S. C.; Fein, L. E.; more...
    Annals of Oncology (2011)

    Fulltext@MSK | Save